Literature DB >> 28345530

Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.

Klaudia Juszczuk1, Katarzyna Grudlewska1, Agnieszka Mikucka1, Eugenia Gospodarek1.   

Abstract

Clostridium difficile is a serious epidemiological problem and particularly dangerous microorganism causing hospital infections. Currently, the treatment of C. difficile infections is the use of metronidazole or vancomycin. However, in some patients, recurrent infection difficult to treat occurs. Fecal microbiota transplantation (FMT) is a new method used to treat the recurrent CDI. FMT consists in the infusion of the fecal suspension from a healthy donor into the gastrointestinal tract of a patient with CDI to restore the natural intestinal microflora. FMT is safe and effective treatment of recurrent CDI. FMT is extensively described around the world, but to date only two randomized studies confirming the effectiveness of FMT have been conducted. This method was also applied in the treatment of diseases such as pseudomembranous colitis, ulcerative colitis, Crohn's disease and irritable bowel syndrome. The review describes the procedure for FMT and the current state of knowledge about the effectiveness of FMT in the treatment of recurrent CDI.

Entities:  

Mesh:

Year:  2017        PMID: 28345530     DOI: 10.5604/01.3001.0010.3807

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  5 in total

1.  Successful Fecal Microbiota Transplant Delivered by Foley Catheter Through a Loop Ileostomy in a Patient With Severe Complicated Clostridioides difficile Infection.

Authors:  Shawn Philip; Omar Tageldin; Muhammed Sohail Mansoor; Seth Richter
Journal:  ACG Case Rep J       Date:  2022-07-12

2.  Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report.

Authors:  Ting Ge; Yizhong Wang; Yanran Che; Yongmei Xiao; Ting Zhang
Journal:  Front Pediatr       Date:  2017-12-12       Impact factor: 3.418

Review 3.  Fecal transplantation: digestive and extradigestive clinical applications.

Authors:  Mihaela Filip; Valentina Tzaneva; Dan L Dumitrascu
Journal:  Clujul Med       Date:  2018-07-31

4.  Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.

Authors:  Wenjia Hui; Ting Li; Weidong Liu; Chunyan Zhou; Feng Gao
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

5.  Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile.

Authors:  Yanxia Wei; Fan Yang; Qiong Wu; Jing Gao; Wenli Liu; Chang Liu; Xiaokui Guo; Sharmila Suwal; Yanbo Kou; Bo Zhang; Yugang Wang; Kuiyang Zheng; Renxian Tang
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.